Nanoform Finland Feed

	Est. tid*
2026-02-26	07:10	Bokslutskommuniké 2025
2025-11-20	07:10	Kvartalsrapport 2025-Q3
2025-08-21	07:10	Kvartalsrapport 2025-Q2
2025-05-20	-	Kvartalsrapport 2025-Q1
2025-04-16	-	X-dag ordinarie utdelning NANOFH 0.00 EUR
2025-04-15	-	Årsstämma
2025-02-27	-	Bokslutskommuniké 2024
2024-11-18	-	Kvartalsrapport 2024-Q3
2024-08-29	-	Kvartalsrapport 2024-Q2
2024-05-30	-	Kvartalsrapport 2024-Q1
2024-04-17	-	X-dag ordinarie utdelning NANOFH 0.00 EUR
2024-04-16	-	Årsstämma
2024-02-29	-	Bokslutskommuniké 2023
2023-11-22	-	Kvartalsrapport 2023-Q3
2023-08-24	-	Kvartalsrapport 2023-Q2
2023-05-25	-	Kvartalsrapport 2023-Q1
2023-04-13	-	X-dag ordinarie utdelning NANOFH 0.00 EUR
2023-04-12	-	Årsstämma
2023-02-28	-	Bokslutskommuniké 2022
2022-11-29	-	Kvartalsrapport 2022-Q3
2022-08-25	-	Kvartalsrapport 2022-Q2
2022-05-24	-	Kvartalsrapport 2022-Q1
2022-04-13	-	X-dag ordinarie utdelning NANOFH 0.00 EUR
2022-04-12	-	Årsstämma
2022-02-22	-	Bokslutskommuniké 2021
2021-11-25	-	Kvartalsrapport 2021-Q3
2021-11-17	-	Extra Bolagsstämma 2021
2021-08-26	-	Kvartalsrapport 2021-Q2
2021-05-27	-	Kvartalsrapport 2021-Q1
2021-04-07	-	X-dag ordinarie utdelning NANOFH 0.00 EUR
2021-04-06	-	Årsstämma
2021-02-26	-	Bokslutskommuniké 2020
2020-11-27	-	Kvartalsrapport 2020-Q3
2020-09-01	-	Extra Bolagsstämma 2020
2020-08-28	-	Kvartalsrapport 2020-Q2

Land	Finland
Lista	First North Finland
Sektor	Hälsovård
Industri	Medicinteknik

2025-05-30 08:45:00 Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström 0,90 EUR | -0,22% | 0,31 MEUR

2025-05-30 08:45:00 Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen 0,90 EUR | -0,22% | 0,31 MEUR

2025-05-28 16:00:00 POSITIVE NANOFORM BIOLOGICS RESPIRATORY DATA TO BE PRESENTED AT DRUG DELIVERY AND FORMULATION SUMMIT 0,90 EUR | -5,46% | 0,35 MEUR

2025-05-20 07:10:00 Nanoform Q1 2025 report: Deal mosaic emerge and commercial value clearly seen in our CESS® technology 0,94 EUR | -2,40% | 0,16 MEUR

2025-05-20 06:45:00 INSIDE INFORMATION MADE PUBLIC: NANOFORM PARTNERS WITH TWO SPECIALIST HEALTHCARE INVESTORS TO DEVELOP AND COMMERCIALISE NANOENCORAFENIB 0,94 EUR | -2,40% | 0,16 MEUR

2025-05-06 10:00:00 Invitation to Nanoform’s Q1 2025 Report Presentation 0,98 EUR | -1,50% | 0,08 MEUR

2025-04-15 13:10:00 Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc 1,10 EUR | -1,79% | 0,02 MEUR

2025-04-15 13:00:00 Resolutions of Nanoform Finland Plc's Annual General Meeting on April 15, 2025 1,10 EUR | -1,79% | 0,02 MEUR

2025-03-17 16:15:00 Kutsu Nanoform Finland Oyj:n varsinaiseen yhtiökokoukseen 1,18 EUR | +0,34% | 0,20 MEUR

2025-03-17 16:15:00 Notice to the Annual General Meeting of NANOFORM FINLAND Plc 1,18 EUR | +0,34% | 0,20 MEUR

2025-02-27 07:10:00 Nanoform 2024 report: Deal discussions around product kernels intensify 1,16 EUR | -5,68% | 0,17 MEUR

2025-02-13 10:00:00 Invitation to Nanoform’s Q4 and FY 2024 Report Presentation 1,15 EUR | -2,21% | 0,05 MEUR

2024-12-18 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Edward Hæggström 1,29 EUR | +2,70% | 0,11 MEUR

2024-12-18 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström 1,29 EUR | +2,70% | 0,11 MEUR

2024-12-18 16:01:00 Nanoform Finland Plc – Managers’ transactions – Antonio Da Silva 1,29 EUR | +2,70% | 0,11 MEUR

2024-12-18 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen 1,29 EUR | +2,70% | 0,11 MEUR

2024-12-18 16:00:00 The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees 1,29 EUR | +2,70% | 0,11 MEUR

2024-11-19 19:45:00 Nanoform Finland Plc – Manager’s Transactions – Peter Hänninen 1,40 EUR | +17,88% | 0,42 MEUR

2024-11-19 19:45:00 Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström 1,40 EUR | +17,88% | 0,42 MEUR

2024-11-18 07:10:00 Nanoform Q3 2024 report: Record number of new projects signed 1,11 EUR | -1,77% | 0,24 MEUR

2024-11-04 10:00:00 Invitation to Nanoform’s Q3 2024 Report Presentation 1,22 EUR | -6,14% | 0,19 MEUR

2024-10-25 15:15:00 Disclosure as attachment of the Nanoform 2022 Report of the Board of Directors and Financial Statements which were previously linked to a Company Release 1,51 EUR | 0,00% | 0,06 MEUR

2024-10-22 18:20:00 Share subscriptions based on Nanoform Finland Plc’s stock options 2/2019 1,51 EUR | -2,58% | 0,07 MEUR

2024-09-05 07:10:00 Nanoform and Celanese Expand Collaboration into Long-Acting Biologics Delivery Through Small Implants 1,85 EUR | 0,00% | 0,07 MEUR

2024-08-29 07:10:00 Nanoform Q2 report: All business targets for 2024 on track 1,85 EUR | +3,13% | 0,20 MEUR

2024-08-16 10:00:00 Invitation to Nanoform’s Q2 2024 Report Presentation 1,72 EUR | -1,04% | 0,06 MEUR

2024-08-15 07:10:00 NANOFORM COLLABORATES WITH TAKEDA ON THEIR PLASMA-DERIVED THERAPY DEVELOPMENT 1,74 EUR | +1,28% | 0,04 MEUR

2024-06-14 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Jeanne Thoma 1,85 EUR | -2,52% | 0,06 MEUR

2024-06-14 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Miguel Calado 1,85 EUR | -2,52% | 0,06 MEUR

2024-06-14 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Albert Hæggström 1,85 EUR | -2,52% | 0,06 MEUR

2024-06-14 16:01:00 Nanoform Finland Plc – Manager’s Transactions – Mads Laustsen 1,85 EUR | -2,52% | 0,06 MEUR

2024-06-14 16:00:00 Share subscriptions based on the resolution by Nanoform Finland Plc’s Annual General Meeting 2024 on remuneration of the Board of Directors 1,85 EUR | -2,52% | 0,06 MEUR

2024-05-30 07:10:00 Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned 1,96 EUR | -7,30% | 1,17 MEUR

2024-05-29 11:30:00 Disclosure of Major Holdings under Law 163/2024 2,11 EUR | -3,65% | 0,11 MEUR

2024-05-16 10:00:00 Invitation to Nanoform’s Q1 2024 Report Presentation 2,00 EUR | +5,08% | 0,14 MEUR

2024-05-07 08:10:00 Nanoformed High-Concentration Biologics Formulation for Subcutaneous Delivery Results to be Presented by Takeda at DDF Summit 2,04 EUR | -3,31% | 0,21 MEUR

2024-04-26 10:00:00 Disclosure of Major Holdings under Law 163/2024 2,15 EUR | +6,16% | 0,50 MEUR

2024-04-25 16:00:00 New shares of Nanoform registered with the trade register 2,03 EUR | -21,77% | 1,24 MEUR

2024-04-24 21:50:00 Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines 2,03 EUR | -21,77% | 1,24 MEUR

2024-04-24 17:31:00 Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines 2,03 EUR | -21,77% | 1,24 MEUR

2024-04-16 12:50:00 Resolutions of the Constitutive Meeting of the Board of Directors of Nanoform Finland Plc 2,54 EUR | -2,69% | 0,61 MEUR

2024-04-16 12:40:00 Resolutions of Nanoform Finland Plc's Annual General Meeting on April 16, 2024 2,54 EUR | -2,69% | 0,61 MEUR

2024-04-11 08:00:00 Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan 2,67 EUR | +1,71% | 0,14 MEUR

2024-04-09 08:00:00 Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer 2,60 EUR | +0,78% | 0,23 MEUR

2024-04-08 08:00:00 Nanoform Finland Plc: Certified Adviser change to Carnegie Investment Bank Ab 2,58 EUR | -1,90% | 0,13 MEUR

2024-03-26 18:30:00 The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals 2,53 EUR | +5,42% | 0,26 MEUR

2024-03-12 17:02:00 Notice to the Annual General Meeting of NANOFORM FINLAND Plc 2,79 EUR | -1,41% | 0,39 MEUR

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Nanoform Finland

Prenumeration

Kalender

Beskrivning

Nanoform Finland

Prenumeration

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden